activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	3358488	CHEMBL1174102	Inhibition of CDC2L5 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	6.5	CHEMBL1795192	Homo sapiens	INH	%	6.5
	3358488	CHEMBL1174102	Inhibition of CDC2L5 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	6.5	CHEMBL1795192	Homo sapiens	INH	%	6.5
	3358930	CHEMBL1174102	Inhibition of CDC2L5 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	13.0	CHEMBL1795192	Homo sapiens	INH	%	13.0
	6384514	CHEMBL1837581	Inhibition of human CHED in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	Nc1c(F)c(NCCCc2ccccc2)c(F)c2c1c(=O)c(C(=O)O)cn2C1CC1		CHEMBL1834114	<	Inhibition	%	35.0	CHEMBL1795192	Homo sapiens	INH	%	35.0
	6384515	CHEMBL1837581	Inhibition of human CHED in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	Nc1c(F)c(NCCNc2ccccn2)c(F)c2c1c(=O)c(C(=O)O)cn2C1CCCC1		CHEMBL1834318	<	Inhibition	%	35.0	CHEMBL1795192	Homo sapiens	INH	%	35.0
	6384516	CHEMBL1837581	Inhibition of human CHED in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	C[C@H]1COc2c(NCCNc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1834323	<	Inhibition	%	35.0	CHEMBL1795192	Homo sapiens	INH	%	35.0
	6384517	CHEMBL1837581	Inhibition of human CHED in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	CC(C)[C@@H]1COc2c(NCCNc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1834324	<	Inhibition	%	35.0	CHEMBL1795192	Homo sapiens	INH	%	35.0
	6384518	CHEMBL1837581	Inhibition of human CHED in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	Nc1c(F)c(NCCNc2ccccn2)c2c3c1c(=O)c(C(=O)O)cn3C1(CCCC1)CO2		CHEMBL1834330	<	Inhibition	%	35.0	CHEMBL1795192	Homo sapiens	INH	%	35.0
	7567320	CHEMBL1908458	Binding constant for CDC2L5 kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	10000.0	CHEMBL1795192	Homo sapiens	Kd	nM	10000.0
	7567779	CHEMBL1908458	Binding constant for CDC2L5 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL1795192	Homo sapiens	Kd	nM	10000.0
	7568276	CHEMBL1908458	Binding constant for CDC2L5 kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	>	Kd	nM	10000.0	CHEMBL1795192	Homo sapiens	Kd	nM	10000.0
	7568708	CHEMBL1908458	Binding constant for CDC2L5 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	10000.0	CHEMBL1795192	Homo sapiens	Kd	nM	10000.0
	7569293	CHEMBL1908458	Binding constant for CDC2L5 kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL1795192	Homo sapiens	Kd	nM	10000.0
	7569753	CHEMBL1908458	Binding constant for CDC2L5 kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	10000.0	CHEMBL1795192	Homo sapiens	Kd	nM	10000.0
	7569783	CHEMBL1908458	Binding constant for CDC2L5 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL1795192	Homo sapiens	Kd	nM	10000.0
	7570246	CHEMBL1908458	Binding constant for CDC2L5 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	>	Kd	nM	10000.0	CHEMBL1795192	Homo sapiens	Kd	nM	10000.0
	7570673	CHEMBL1908458	Binding constant for CDC2L5 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL1795192	Homo sapiens	Kd	nM	10000.0
	7571269	CHEMBL1908458	Binding constant for CDC2L5 kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	10000.0	CHEMBL1795192	Homo sapiens	Kd	nM	10000.0
	7571760	CHEMBL1908458	Binding constant for CDC2L5 kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	10000.0	CHEMBL1795192	Homo sapiens	Kd	nM	10000.0
	7572223	CHEMBL1908458	Binding constant for CDC2L5 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL1795192	Homo sapiens	Kd	nM	10000.0
	7572639	CHEMBL1908458	Binding constant for CDC2L5 kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	>	Kd	nM	10000.0	CHEMBL1795192	Homo sapiens	Kd	nM	10000.0
	7573265	CHEMBL1908458	Binding constant for CDC2L5 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL1795192	Homo sapiens	Kd	nM	10000.0
	7573741	CHEMBL1908458	Binding constant for CDC2L5 kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	>	Kd	nM	10000.0	CHEMBL1795192	Homo sapiens	Kd	nM	10000.0
	7574210	CHEMBL1908458	Binding constant for CDC2L5 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL1795192	Homo sapiens	Kd	nM	10000.0
	7574618	CHEMBL1908458	Binding constant for CDC2L5 kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL1795192	Homo sapiens	Kd	nM	10000.0
	7574786	CHEMBL1908458	Binding constant for CDC2L5 kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	10000.0	CHEMBL1795192	Homo sapiens	Kd	nM	10000.0
	7575247	CHEMBL1908458	Binding constant for CDC2L5 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL1795192	Homo sapiens	Kd	nM	10000.0
	7575718	CHEMBL1908458	Binding constant for CDC2L5 kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	>	Kd	nM	10000.0	CHEMBL1795192	Homo sapiens	Kd	nM	10000.0
	7576183	CHEMBL1908458	Binding constant for CDC2L5 kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	>	Kd	nM	10000.0	CHEMBL1795192	Homo sapiens	Kd	nM	10000.0
	7576591	CHEMBL1908458	Binding constant for CDC2L5 kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	10000.0	CHEMBL1795192	Homo sapiens	Kd	nM	10000.0
	7576760	CHEMBL1908458	Binding constant for CDC2L5 kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL1795192	Homo sapiens	Kd	nM	10000.0
	7577219	CHEMBL1908458	Binding constant for CDC2L5 kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	Kd	nM	210.0	CHEMBL1795192	Homo sapiens	Kd	nM	210.0
	7577697	CHEMBL1908458	Binding constant for CDC2L5 kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	10000.0	CHEMBL1795192	Homo sapiens	Kd	nM	10000.0
	7578167	CHEMBL1908458	Binding constant for CDC2L5 kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	>	Kd	nM	10000.0	CHEMBL1795192	Homo sapiens	Kd	nM	10000.0
	7578572	CHEMBL1908458	Binding constant for CDC2L5 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL1795192	Homo sapiens	Kd	nM	10000.0
	7578768	CHEMBL1908458	Binding constant for CDC2L5 kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	=	Kd	nM	3100.0	CHEMBL1795192	Homo sapiens	Kd	nM	3100.0
	7579142	CHEMBL1908458	Binding constant for CDC2L5 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Kd	nM	1100.0	CHEMBL1795192	Homo sapiens	Kd	nM	1100.0
	7579592	CHEMBL1908458	Binding constant for CDC2L5 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	430.0	CHEMBL1795192	Homo sapiens	Kd	nM	430.0
	7580066	CHEMBL1908458	Binding constant for CDC2L5 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL1795192	Homo sapiens	Kd	nM	10000.0
	7581126	CHEMBL1908458	Binding constant for CDC2L5 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL1795192	Homo sapiens	Kd	nM	10000.0
	7581511	CHEMBL1908458	Binding constant for CDC2L5 kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	=	Kd	nM	800.0	CHEMBL1795192	Homo sapiens	Kd	nM	800.0
	7581956	CHEMBL1908458	Binding constant for CDC2L5 kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL1795192	Homo sapiens	Kd	nM	10000.0
	7582427	CHEMBL1908458	Binding constant for CDC2L5 kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	10000.0	CHEMBL1795192	Homo sapiens	Kd	nM	10000.0
	7582449	CHEMBL1908458	Binding constant for CDC2L5 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL1795192	Homo sapiens	Kd	nM	10000.0
	7582849	CHEMBL1908458	Binding constant for CDC2L5 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL1795192	Homo sapiens	Kd	nM	10000.0
	7583472	CHEMBL1908458	Binding constant for CDC2L5 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	Kd	nM	38.0	CHEMBL1795192	Homo sapiens	Kd	nM	38.0
	7583869	CHEMBL1908458	Binding constant for CDC2L5 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	=	Kd	nM	23.0	CHEMBL1795192	Homo sapiens	Kd	nM	23.0
	7584314	CHEMBL1908458	Binding constant for CDC2L5 kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL1795192	Homo sapiens	Kd	nM	10000.0
	7584805	CHEMBL1908458	Binding constant for CDC2L5 kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	10000.0	CHEMBL1795192	Homo sapiens	Kd	nM	10000.0
	7585209	CHEMBL1908458	Binding constant for CDC2L5 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL1795192	Homo sapiens	Kd	nM	10000.0
	7585802	CHEMBL1908458	Binding constant for CDC2L5 kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL1795192	Homo sapiens	Kd	nM	10000.0
	7586210	CHEMBL1908458	Binding constant for CDC2L5 kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL1795192	Homo sapiens	Kd	nM	10000.0
	7586685	CHEMBL1908458	Binding constant for CDC2L5 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL1795192	Homo sapiens	Kd	nM	10000.0
	7587139	CHEMBL1908458	Binding constant for CDC2L5 kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	=	Kd	nM	110.0	CHEMBL1795192	Homo sapiens	Kd	nM	110.0
	7587763	CHEMBL1908458	Binding constant for CDC2L5 kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	10000.0	CHEMBL1795192	Homo sapiens	Kd	nM	10000.0
	7588193	CHEMBL1908458	Binding constant for CDC2L5 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL1795192	Homo sapiens	Kd	nM	10000.0
	7588664	CHEMBL1908458	Binding constant for CDC2L5 kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL1795192	Homo sapiens	Kd	nM	10000.0
	7589115	CHEMBL1908458	Binding constant for CDC2L5 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL1795192	Homo sapiens	Kd	nM	10000.0
	7589710	CHEMBL1908458	Binding constant for CDC2L5 kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	1000.0	CHEMBL1795192	Homo sapiens	Kd	nM	1000.0
	7590177	CHEMBL1908458	Binding constant for CDC2L5 kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL1795192	Homo sapiens	Kd	nM	10000.0
	7590651	CHEMBL1908458	Binding constant for CDC2L5 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL1795192	Homo sapiens	Kd	nM	10000.0
	7591102	CHEMBL1908458	Binding constant for CDC2L5 kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL1795192	Homo sapiens	Kd	nM	10000.0
	7591259	CHEMBL1908458	Binding constant for CDC2L5 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL1795192	Homo sapiens	Kd	nM	10000.0
	7591681	CHEMBL1908458	Binding constant for CDC2L5 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL1795192	Homo sapiens	Kd	nM	10000.0
	7592153	CHEMBL1908458	Binding constant for CDC2L5 kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL1795192	Homo sapiens	Kd	nM	10000.0
	7592626	CHEMBL1908458	Binding constant for CDC2L5 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL1795192	Homo sapiens	Kd	nM	10000.0
	7593079	CHEMBL1908458	Binding constant for CDC2L5 kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	10000.0	CHEMBL1795192	Homo sapiens	Kd	nM	10000.0
	7593226	CHEMBL1908458	Binding constant for CDC2L5 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	0.94	CHEMBL1795192	Homo sapiens	Kd	nM	0.94
	7593661	CHEMBL1908458	Binding constant for CDC2L5 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL1795192	Homo sapiens	Kd	nM	10000.0
	7594133	CHEMBL1908458	Binding constant for CDC2L5 kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL1795192	Homo sapiens	Kd	nM	10000.0
	7594606	CHEMBL1908458	Binding constant for CDC2L5 kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	10000.0	CHEMBL1795192	Homo sapiens	Kd	nM	10000.0
	7595058	CHEMBL1908458	Binding constant for CDC2L5 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL1795192	Homo sapiens	Kd	nM	10000.0
	7595194	CHEMBL1908458	Binding constant for CDC2L5 kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	=	Kd	nM	3.2	CHEMBL1795192	Homo sapiens	Kd	nM	3.2
	7595638	CHEMBL1908458	Binding constant for CDC2L5 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL1795192	Homo sapiens	Kd	nM	10000.0
	7596112	CHEMBL1908458	Binding constant for CDC2L5 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL1795192	Homo sapiens	Kd	nM	10000.0
	7596583	CHEMBL1908458	Binding constant for CDC2L5 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL1795192	Homo sapiens	Kd	nM	10000.0
	7597166	CHEMBL1908458	Binding constant for CDC2L5 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	=	Kd	nM	1100.0	CHEMBL1795192	Homo sapiens	Kd	nM	1100.0
	7597619	CHEMBL1908458	Binding constant for CDC2L5 kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL1795192	Homo sapiens	Kd	nM	10000.0
	7598092	CHEMBL1908458	Binding constant for CDC2L5 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	10000.0	CHEMBL1795192	Homo sapiens	Kd	nM	10000.0
	7598562	CHEMBL1908458	Binding constant for CDC2L5 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	70.0	CHEMBL1795192	Homo sapiens	Kd	nM	70.0
	8003444	CHEMBL1944422	Inhibition of human CHED in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCn3cccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1940980	<	Inhibition	%	35.0	CHEMBL1795192	Homo sapiens	INH	%	35.0
	8003445	CHEMBL1944422	Inhibition of human CHED in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCn3cccn3)c(F)c(N)c3c(=O)c(C#N)cn1c23		CHEMBL1940981	<	Inhibition	%	35.0	CHEMBL1795192	Homo sapiens	INH	%	35.0
	8003446	CHEMBL1944422	Inhibition of human CHED in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1940987	<	Inhibition	%	35.0	CHEMBL1795192	Homo sapiens	INH	%	35.0
	8003447	CHEMBL1944422	Inhibition of human CHED in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCc3ccccn3)c(F)c(N)c3c(=O)c(C#N)cn1c23		CHEMBL1940990	<	Inhibition	%	35.0	CHEMBL1795192	Homo sapiens	INH	%	35.0
	12173703	CHEMBL2209339	Inhibition of CDC2L5 assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	100.0	CHEMBL1795192	Homo sapiens	Activity	%	100.0
Inactive	17888981	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1		CHEMBL3991932	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17888982	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17888983	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17888984	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17888985	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21		CHEMBL3545366	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17888986	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1		CHEMBL2103842	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17888987	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1		CHEMBL1822792	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17888988	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17888989	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL2017974	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17888990	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl		CHEMBL3991935	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17888991	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL1614766	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17888992	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1		CHEMBL270995	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17888993	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1		CHEMBL1952329	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17888994	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12		CHEMBL3120215	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17888995	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1		CHEMBL3039525	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17888996	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17888997	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17888998	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17888999	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889000	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889001	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889002	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889003	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL3699142	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889004	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3218576	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889005	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL3545154	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889006	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1		CHEMBL496102	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Active	17889007	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Kd	nM	4518.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	4518.0
Inactive	17889008	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL206834	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889009	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F		CHEMBL3188267	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889010	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889011	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O		CHEMBL536151	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889012	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL3545360	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889013	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889014	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3991931	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889015	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1		CHEMBL2180604	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Active	17889016	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	=	Kd	nM	21.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	21.0
Inactive	17889017	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL1229517	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889018	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1		CHEMBL2386889	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889019	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL1078178	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889020	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889021	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F		CHEMBL3039513	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889022	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1		CHEMBL3301612	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889023	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889024	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1		CHEMBL1236682	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889025	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889026	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1		CHEMBL3813873	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889027	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889028	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889029	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F		CHEMBL3188551	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889030	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889031	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889032	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1		CHEMBL1234354	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889033	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889034	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889035	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889036	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1		CHEMBL2087361	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889037	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1		CHEMBL3544932	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889038	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889039	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL2165191	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889040	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889041	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17889042	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1		CHEMBL2140408	=	Kd	nM	2507.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	2507.0
Inactive	17889043	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1		CHEMBL1231124	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889044	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1		CHEMBL551064	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889045	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1		CHEMBL3545085	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889046	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1.Cl		CHEMBL3991929	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889047	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]ccc2cc(OC3CCNCC3)ccc12		CHEMBL1667969	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889048	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1		CHEMBL3590106	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889049	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889050	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889051	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1		CHEMBL3545308	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889052	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889053	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889054	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889055	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2/C=C/c2cc[n+]([O-])cc2)cc1		CHEMBL3991927	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889056	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408248	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889057	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1		CHEMBL592445	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889058	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1		CHEMBL2035187	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889059	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889060	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F		CHEMBL2107832	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889061	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889062	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL403989	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889063	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889064	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889065	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Active	17889066	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1		CHEMBL3544964	=	Kd	nM	5744.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	5744.0
Inactive	17889067	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1		CHEMBL3991933	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889068	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1		CHEMBL1233300	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889069	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Active	17889070	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	=	Kd	nM	356.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	356.0
Inactive	17889071	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1		CHEMBL2336325	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889072	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889073	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1		CHEMBL1241855	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889074	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL1230165	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889075	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(-c3cnn(C)c3)nc21		CHEMBL3334567	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889076	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1		CHEMBL1950289	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889077	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1908360	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889078	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1		CHEMBL598797	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889079	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21		CHEMBL3545215	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889080	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F		CHEMBL1090090	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889081	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1		CHEMBL587723	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889082	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1		CHEMBL3039517	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889083	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO		CHEMBL1801204	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889084	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889085	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889086	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1		CHEMBL3544983	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889087	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12		CHEMBL2103882	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889088	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889089	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889090	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889091	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl		CHEMBL3137336	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889092	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889093	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1		CHEMBL2041933	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889094	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Active	17889095	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	=	Kd	nM	203.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	203.0
Inactive	17889096	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC		CHEMBL405130	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889097	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3184679	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889098	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1cnc2ccc(-c3cc(Cl)c(O)c(Cl)c3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL3688339	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889099	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889100	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889101	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O		CHEMBL3182621	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Active	17889102	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331	=	Kd	nM	3107.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	3107.0
Inactive	17889103	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889104	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1		CHEMBL2133806	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889105	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889106	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C		CHEMBL488436	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889107	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889108	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1		CHEMBL3544966	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889109	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1		CHEMBL2103851	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889110	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889111	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1		CHEMBL571948	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889112	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3545110	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889113	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1201182	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889114	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889115	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889116	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889117	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12		CHEMBL1614710	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889118	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889119	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1		CHEMBL3989868	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889120	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889121	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889122	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)C(=O)CC[C@@H]12)CC=C		CHEMBL411907	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889123	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889124	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1		CHEMBL3301622	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889125	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL2103830	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889126	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889127	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F		CHEMBL3264002	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889128	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1		CHEMBL2105728	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889129	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCc1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)c(F)c2)c2c(N)ncnn2c1CN1CCOCC1		CHEMBL3991934	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889130	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C		CHEMBL1233528	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889131	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889132	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889133	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1C#CC(C)(C)N1CCN(C)CC1		CHEMBL2138625	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889134	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889135	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1		CHEMBL2048872	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889136	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889137	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1		CHEMBL2323775	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889138	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2376648	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889139	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1N=C(N)c2cn([C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL462018	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889140	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1		CHEMBL3545137	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889141	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889142	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1		CHEMBL3545328	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889143	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL2325741	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889144	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889145	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889146	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1		CHEMBL3348923	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889147	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1		CHEMBL3544960	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889148	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889149	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12		CHEMBL1645462	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889150	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889151	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889152	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1		CHEMBL2079588	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889153	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889154	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1		CHEMBL3545396	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Active	17889155	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	=	Kd	nM	3582.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	3582.0
Inactive	17889156	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1		CHEMBL3218575	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889157	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922094	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889158	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1		CHEMBL2146883	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889159	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1		CHEMBL1079175	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889160	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL1944698	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889161	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889162	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1		CHEMBL575448	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889163	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1		CHEMBL1614707	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889164	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889165	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Active	17889166	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	=	Kd	nM	4503.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	4503.0
Inactive	17889167	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889168	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889169	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL2408045	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889170	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889171	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1		CHEMBL1738757	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889172	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1		CHEMBL3182444	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889173	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889174	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889175	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889176	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889177	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1		CHEMBL2110732	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889178	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1		CHEMBL3545076	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889179	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1		CHEMBL1614713	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889180	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889181	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL2103839	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889182	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889183	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889184	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21		CHEMBL3187723	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889185	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889186	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889187	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889188	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889189	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1		CHEMBL2028663	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889190	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889191	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889192	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1		CHEMBL254760	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889193	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889194	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1		CHEMBL3186534	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Active	17889195	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	1814.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	1814.0
Inactive	17889196	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1		CHEMBL2103875	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889197	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889198	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889199	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889200	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12		CHEMBL3426621	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889201	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Active	17889202	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1		CHEMBL3545083	=	Kd	nM	1012.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	1012.0
Inactive	17889203	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1		CHEMBL372764	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889204	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889205	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1		CHEMBL3218578	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889206	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1		CHEMBL3402762	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889207	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1		CHEMBL3545307	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889208	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL2396661	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889209	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3		CHEMBL3109738	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889210	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889211	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12		CHEMBL3544944	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889212	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889213	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889214	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889215	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889216	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889217	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl		CHEMBL2219422	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889218	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1		CHEMBL1091644	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889219	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889220	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889221	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889222	CHEMBL3991653	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B			CHEMBL4084193	>	Kd	nM	30000.0	CHEMBL1795192	Homo sapiens	Kd apparent	nM	30000.0
	18114445	CHEMBL4025049	Inhibition of wild-type human partial length CDC2L5 (H675 to S1054 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	100.0	CHEMBL1795192	Homo sapiens	Activity	%	100.0
	18203573	CHEMBL4043860	Inhibition of wild-type human partial length CDC2L5 (H675 to S1054 residues) expressed in HEK293 cells assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	100.0	CHEMBL1795192	Homo sapiens	Activity	%	100.0
	18253407	CHEMBL4054987	Inhibition of wild-type human partial length CDC2L5 (H675 to S1054 residues) expressed in mammalian expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	72.0	CHEMBL1795192	Homo sapiens	Activity	%	72.0
	18253408	CHEMBL4054987	Inhibition of wild-type human partial length CDC2L5 (H675 to S1054 residues) expressed in mammalian expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	100.0	CHEMBL1795192	Homo sapiens	Activity	%	100.0
	18274839	CHEMBL4118325	Inhibition of CHED in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DIKCSNILLNNR probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl	Outside typical range	CHEMBL3883384	=	Inhibition	%	-23.7	CHEMBL1795192	Homo sapiens	INH	%	-23.7
	18274840	CHEMBL4118325	Inhibition of CHED in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DIKCSNILLNNR probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2cnn(CCOC)c2)ncc1Cl	Outside typical range	CHEMBL3884839	=	Inhibition	%	-19.2	CHEMBL1795192	Homo sapiens	INH	%	-19.2
	18274841	CHEMBL4118325	Inhibition of CHED in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DIKCSNILLNNR probe by mass-spectrometric analysis relative to control	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O	Outside typical range	CHEMBL1077979	=	Inhibition	%	-24.8	CHEMBL1795192	Homo sapiens	INH	%	-24.8
	18440115	CHEMBL4156939	Binding affinity to wild-type human partial length CDC2L5 (H675 to S1054 residues) expressed in mammalian expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	100.0	CHEMBL1795192	Homo sapiens	Activity	%	100.0
	18484555	CHEMBL4185718	Binding affinity to wild-type human partial length CDC2L5 (H675 to S1054 residues) expressed in HEK293 cells at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	100.0	CHEMBL1795192	Homo sapiens	Activity	%	100.0
	18485066	CHEMBL4185718	Binding affinity to wild-type human partial length CDC2L5 (H675 to S1054 residues) expressed in HEK293 cells at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	99.0	CHEMBL1795192	Homo sapiens	Activity	%	99.0
	18655617	CHEMBL4230618	Binding affinity to wild-type human partial length CDC2L5 (H675 to S1054 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	100.0	CHEMBL1795192	Homo sapiens	Activity	%	100.0
	18751696	CHEMBL4264207	Binding affinity to wild-type human partial length CDC2L5 (H675 to S1054 residues) expressed in mammalian expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	13.0	CHEMBL1795192	Homo sapiens	Activity	%	13.0
	18857877	CHEMBL4307723	Binding affinity to wild-type human partial length CDC2L5 (H675 to S1054 residues) expressed in mammalian expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	99.0	CHEMBL1795192	Homo sapiens	Activity	%	99.0
	18958795	CHEMBL4333314	Binding affinity to wild-type human partial length CDC2L5 (H675 to S1054 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	84.0	CHEMBL1795192	Homo sapiens	Activity	%	84.0
	19059495	CHEMBL4357796	Binding affinity to wild-type human partial length CDC2L5 (H675 to S1054 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	92.0	CHEMBL1795192	Homo sapiens	Activity	%	92.0
	19090067	CHEMBL4365641	Inhibition of wild-type human partial length CDC2L5 (H675 to S1054 residues) expressed in mammalian expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	100.0	CHEMBL1795192	Homo sapiens	Activity	%	100.0
	19159323	CHEMBL4382427	Binding affinity to wild-type human partial length CDC2L5 (H675 to S1054 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	91.0	CHEMBL1795192	Homo sapiens	Activity	%	91.0
	19191684	CHEMBL4389146	Inhibition of wild-type human partial length CDC2L5 (H675 to S1054 residues) expressed in mammalian expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	97.0	CHEMBL1795192	Homo sapiens	INH	%	97.0
	19191809	CHEMBL4389623	Inhibition of wild-type human partial length CDC2L5 (H675 to S1054 residues) expressed in mammalian expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	96.0	CHEMBL1795192	Homo sapiens	INH	%	96.0
	19199973	CHEMBL4391249	Binding affinity to wild-type human partial length CDC2L5 (H675 to S1054 residues) expressed in mammalian expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	0.61	CHEMBL1795192	Homo sapiens	Activity	%	0.61
	20636355	CHEMBL4611866	Inhibition of CDK13 (unknown origin)	B	Cc1cc(NC2CCN(C(=O)O[C@H]3CCN(C(=O)/C=C/CN(C)C)C3)CC2)n2ncc(C(C)C)c2n1		CHEMBL4635959	>	IC50	nM	8000.0	CHEMBL1795192	Homo sapiens	IC50	uM	8.0
	20636379	CHEMBL4611866	Inhibition of CDK13 (unknown origin)	B	CN(C)C/C=C/C(=O)Nc1ccc(C(=O)Nc2cccc(Nc3ncc(Cl)c(-c4c[nH]c5ccccc45)n3)c2)cc1		CHEMBL3603847	=	IC50	nM	628.0	CHEMBL1795192	Homo sapiens	IC50	nM	628.0
Active	20639704	CHEMBL4612769	Binding affinity to wild-type human partial length CDK13 (H675 to S1054 residues) expressed in mammalian expression system at 1 uM by Kinomescan method	B	C=CC(=O)Nc1ccc(C(=O)N2CCC[C@@H](Nc3ncc(SCc4ncc(C(C)(C)C)o4)s3)C2)cc1		CHEMBL4647764		Activity			CHEMBL1795192	Homo sapiens	Activity		
Active	20639731	CHEMBL4612793	Inhibition of CDK13 C1017S mutant in human HAP1 cells assessed as reduction in RNA Polymerase 2 CTD phosphorylation at Ser2 residues at 40 to 200 nM measured after 6 hrs by Western blot analysis	B	C=CC(=O)Nc1ccc(C(=O)N2CCC[C@@H](Nc3ncc(SCc4ncc(C(C)(C)C)o4)s3)C2)cc1		CHEMBL4647764		Inhibition	%		CHEMBL1795192	Homo sapiens	INH		
Active	20639732	CHEMBL4612794	Inhibition of CDK13 C1017S mutant in human HAP1 cells assessed as reduction in RNA Polymerase 2 CTD phosphorylation at Ser5 residues at 40 to 200 nM measured after 6 hrs by Western blot analysis	B	C=CC(=O)Nc1ccc(C(=O)N2CCC[C@@H](Nc3ncc(SCc4ncc(C(C)(C)C)o4)s3)C2)cc1		CHEMBL4647764		Inhibition	%		CHEMBL1795192	Homo sapiens	INH		
Active	20639733	CHEMBL4612795	Inhibition of CDK13 C1017S mutant in human HAP1 cells assessed as reduction in RNA Polymerase 2 CTD phosphorylation at Ser7 residues at 40 to 200 nM measured after 6 hrs by Western blot analysis	B	C=CC(=O)Nc1ccc(C(=O)N2CCC[C@@H](Nc3ncc(SCc4ncc(C(C)(C)C)o4)s3)C2)cc1		CHEMBL4647764		Inhibition	%		CHEMBL1795192	Homo sapiens	INH		
Active	20639734	CHEMBL4612796	Inhibition of CDK13 C1017S mutant in human HAP1 cells assessed as reduction in RNA Polymerase 2 expression at 40 to 200 nM measured after 6 hrs by Western blot analysis	B	C=CC(=O)Nc1ccc(C(=O)N2CCC[C@@H](Nc3ncc(SCc4ncc(C(C)(C)C)o4)s3)C2)cc1		CHEMBL4647764		Inhibition	%		CHEMBL1795192	Homo sapiens	INH		
	20641542	CHEMBL4613419	Inhibition of CDK13 (unknown origin)	B	CN(C)C/C=C/C(=O)Nc1ccc(C(=O)N2CCC[C@H](Nc3ncc(Cl)c(-c4c[nH]c5ccccc45)n3)C2)cc1		CHEMBL4648857	=	IC50	nM	69.0	CHEMBL1795192	Homo sapiens	IC50	nM	69.0
	22941206	CHEMBL4739836	Inhibition of kinase tracer 236 binding to CDK13 (unknown origin) by FRET based Lantha screen Eu kinase binding assay	B	C=CC(=O)Nc1ccc(-c2ccc(C(C)C(=O)Nc3cc(C4CC4)[nH]n3)cc2)cc1		CHEMBL4750818	=	IC50	nM	24.0	CHEMBL1795192	Homo sapiens	IC50	uM	0.024
	22941207	CHEMBL4739836	Inhibition of kinase tracer 236 binding to CDK13 (unknown origin) by FRET based Lantha screen Eu kinase binding assay	B	C=CC(=O)Nc1ccc(-c2ccc(C(C)C(=O)Nc3cc(C4CC4)[nH]n3)cc2)cc1		CHEMBL4750818	=	IC50	nM	18.0	CHEMBL1795192	Homo sapiens	IC50	uM	0.018000000000000002
	22941208	CHEMBL4739836	Inhibition of kinase tracer 236 binding to CDK13 (unknown origin) by FRET based Lantha screen Eu kinase binding assay	B	C=CC(=O)NCc1ccc(-c2ccc(C(C)C(=O)Nc3cc(C4CC4)[nH]n3)cn2)cn1		CHEMBL4759298	=	IC50	nM	4.0	CHEMBL1795192	Homo sapiens	IC50	uM	0.004
	22941209	CHEMBL4739836	Inhibition of kinase tracer 236 binding to CDK13 (unknown origin) by FRET based Lantha screen Eu kinase binding assay	B	CC(C(=O)Nc1cc(C2CC2)[nH]n1)c1ccc(-c2ccc(NC(=O)/C=C/CN3CCOCC3)nc2)cc1		CHEMBL4740577	=	IC50	nM	24.0	CHEMBL1795192	Homo sapiens	IC50	uM	0.024
	22941210	CHEMBL4739836	Inhibition of kinase tracer 236 binding to CDK13 (unknown origin) by FRET based Lantha screen Eu kinase binding assay	B	CC(C(=O)Nc1cc(C2CC2)[nH]n1)c1ccc(-c2ccc(NC(=O)/C=C/CN3CCOCC3)nc2)cc1		CHEMBL4740577	=	IC50	nM	500.0	CHEMBL1795192	Homo sapiens	IC50	uM	0.5
	22941211	CHEMBL4739836	Inhibition of kinase tracer 236 binding to CDK13 (unknown origin) by FRET based Lantha screen Eu kinase binding assay	B	CC(C(=O)Nc1cc(C2CC2)[nH]n1)c1ccc(-c2ccc(NC(=O)/C=C/CN3CCOCC3)nc2)cc1		CHEMBL4740577	=	IC50	nM	5.0	CHEMBL1795192	Homo sapiens	IC50	uM	0.005
	22941212	CHEMBL4739836	Inhibition of kinase tracer 236 binding to CDK13 (unknown origin) by FRET based Lantha screen Eu kinase binding assay	B	C=CC(=O)NCc1ccc(-c2ccc([C@H](C)C(=O)Nc3cc(C4CC4)[nH]n3)cc2)cn1		CHEMBL4760738	=	IC50	nM	3.8	CHEMBL1795192	Homo sapiens	IC50	uM	0.0038
	22941213	CHEMBL4739836	Inhibition of kinase tracer 236 binding to CDK13 (unknown origin) by FRET based Lantha screen Eu kinase binding assay	B	C=CC(=O)NCc1ccc(-c2ccc(C(C)C(=O)Nc3cc(C4CC4)[nH]n3)cc2)cc1		CHEMBL4762563	=	IC50	nM	16.9	CHEMBL1795192	Homo sapiens	IC50	uM	0.0169
	22941214	CHEMBL4739836	Inhibition of kinase tracer 236 binding to CDK13 (unknown origin) by FRET based Lantha screen Eu kinase binding assay	B	C=CC(=O)NCc1ccc(-c2ccc(C(C)C(=O)Nc3cc(C4CC4)[nH]n3)cc2)cc1		CHEMBL4762563	=	IC50	nM	804.0	CHEMBL1795192	Homo sapiens	IC50	uM	0.804
	22941215	CHEMBL4739836	Inhibition of kinase tracer 236 binding to CDK13 (unknown origin) by FRET based Lantha screen Eu kinase binding assay	B	C=CC(=O)NCc1ccc(-c2ccc(C(C)C(=O)Nc3cc(C4CC4)[nH]n3)cc2)cc1		CHEMBL4762563	=	IC50	nM	96.0	CHEMBL1795192	Homo sapiens	IC50	uM	0.096
	22941216	CHEMBL4739836	Inhibition of kinase tracer 236 binding to CDK13 (unknown origin) by FRET based Lantha screen Eu kinase binding assay	B	CC(C(=O)Nc1cc(C2CC2)[nH]n1)c1ccc(-c2ccc(NC(=O)/C=C/CN3CCOCC3)cc2)cc1		CHEMBL4744778	=	IC50	nM	60.8	CHEMBL1795192	Homo sapiens	IC50	uM	0.0608
	22941217	CHEMBL4739836	Inhibition of kinase tracer 236 binding to CDK13 (unknown origin) by FRET based Lantha screen Eu kinase binding assay	B	CC(C(=O)Nc1cc(C2CC2)[nH]n1)c1ccc(-c2ccc(NC(=O)/C=C/CN3CCOCC3)cc2)cc1		CHEMBL4744778	=	IC50	nM	3.9	CHEMBL1795192	Homo sapiens	IC50	uM	0.0039
	22941218	CHEMBL4739836	Inhibition of kinase tracer 236 binding to CDK13 (unknown origin) by FRET based Lantha screen Eu kinase binding assay	B	CC(C(=O)Nc1cc(C2CC2)[nH]n1)c1ccc(-c2ccc(NC(=O)/C=C/CN3CCOCC3)cc2)cc1		CHEMBL4744778	=	IC50	nM	2064.0	CHEMBL1795192	Homo sapiens	IC50	uM	2.064
	22941219	CHEMBL4739836	Inhibition of kinase tracer 236 binding to CDK13 (unknown origin) by FRET based Lantha screen Eu kinase binding assay	B	CC(C(=O)Nc1cc(C2CC2)[nH]n1)c1ccc(-c2ccc(CNC(=O)/C=C/CN3CCOCC3)cc2)cc1		CHEMBL4798265	=	IC50	nM	256.6	CHEMBL1795192	Homo sapiens	IC50	uM	0.2566
	22941220	CHEMBL4739836	Inhibition of kinase tracer 236 binding to CDK13 (unknown origin) by FRET based Lantha screen Eu kinase binding assay	B	CC(C(=O)Nc1cc(C2CC2)[nH]n1)c1ccc(-c2ccc(NC(=O)/C=C/CN3CCOCC3)cc2)cc1		CHEMBL4744778	=	IC50	nM	212.0	CHEMBL1795192	Homo sapiens	IC50	uM	0.212
	22941221	CHEMBL4739836	Inhibition of kinase tracer 236 binding to CDK13 (unknown origin) by FRET based Lantha screen Eu kinase binding assay	B	CC(C(=O)Nc1cc(C2CC2)[nH]n1)c1ccc(-c2ccc(NC(=O)/C=C/CN3CCOCC3)cc2)cc1		CHEMBL4744778	=	IC50	nM	53.6	CHEMBL1795192	Homo sapiens	IC50	uM	0.0536
	22941222	CHEMBL4739836	Inhibition of kinase tracer 236 binding to CDK13 (unknown origin) by FRET based Lantha screen Eu kinase binding assay	B	C=CC(=O)NC1(c2ccc(-c3ccc([C@H](C)C(=O)Nc4cc(C5CC5)[nH]n4)cc3)cn2)CC1		CHEMBL4746619	=	IC50	nM	119.0	CHEMBL1795192	Homo sapiens	IC50	uM	0.11900000000000001
	22941223	CHEMBL4739836	Inhibition of kinase tracer 236 binding to CDK13 (unknown origin) by FRET based Lantha screen Eu kinase binding assay	B	C=CC(=O)NC(CC)c1ccc(-c2ccc([C@H](C)C(=O)Nc3cc(C4CC4)[nH]n3)cc2)cn1		CHEMBL4792587	=	IC50	nM	13.0	CHEMBL1795192	Homo sapiens	IC50	uM	0.013000000000000001
	22941224	CHEMBL4739836	Inhibition of kinase tracer 236 binding to CDK13 (unknown origin) by FRET based Lantha screen Eu kinase binding assay	B	C=CC(=O)NC(C)c1ccc(-c2ccc([C@H](C)C(=O)Nc3cc(C4CC4)[nH]n3)cc2)cn1		CHEMBL4754339	=	IC50	nM	36.2	CHEMBL1795192	Homo sapiens	IC50	uM	0.0362
	22941225	CHEMBL4739836	Inhibition of kinase tracer 236 binding to CDK13 (unknown origin) by FRET based Lantha screen Eu kinase binding assay	B	C=CC(=O)NCc1ncc(-c2ccc([C@H](C)C(=O)Nc3cc(C4CC4)[nH]n3)cc2)cc1F		CHEMBL4740663	=	IC50	nM	87.7	CHEMBL1795192	Homo sapiens	IC50	uM	0.0877
	22941226	CHEMBL4739836	Inhibition of kinase tracer 236 binding to CDK13 (unknown origin) by FRET based Lantha screen Eu kinase binding assay	B	C=CC(=O)NCc1ccc(-c2ccc(C(C)C(=O)Nc3cc(C4CC4)[nH]n3)cc2)nc1		CHEMBL4789071	=	IC50	nM	20.9	CHEMBL1795192	Homo sapiens	IC50	uM	0.0209
	22941227	CHEMBL4739836	Inhibition of kinase tracer 236 binding to CDK13 (unknown origin) by FRET based Lantha screen Eu kinase binding assay	B	C=CC(=O)NCc1ccc(C(C)C(=O)Nc2cc(C3CC3)[nH]n2)cc1		CHEMBL4759113	=	IC50	nM	280.0	CHEMBL1795192	Homo sapiens	IC50	uM	0.28
	22941228	CHEMBL4739836	Inhibition of kinase tracer 236 binding to CDK13 (unknown origin) by FRET based Lantha screen Eu kinase binding assay	B	C=CC(=O)NCc1ccc(C(C)C(=O)Nc2cc(C3CC3)[nH]n2)cc1		CHEMBL4759113	=	IC50	nM	236.0	CHEMBL1795192	Homo sapiens	IC50	uM	0.23600000000000002
	22941229	CHEMBL4739836	Inhibition of kinase tracer 236 binding to CDK13 (unknown origin) by FRET based Lantha screen Eu kinase binding assay	B	C=CC(=O)NCc1ccc(C(C)C(=O)Nc2cc(C3CC3)[nH]n2)cn1		CHEMBL4795410	=	IC50	nM	328.0	CHEMBL1795192	Homo sapiens	IC50	uM	0.32799999999999996
	22945140	CHEMBL4742551	Binding affinity to CDK13 (unknown origin) by TR-FRET assay	B	C=CC(=O)N1CC=C(c2ccc(C(C)C(=O)Nc3cc(C4CC4)[nH]n3)cc2)CC1		CHEMBL4778214	=	IC50	nM	12.0	CHEMBL1795192	Homo sapiens	IC50	uM	0.012
	22945141	CHEMBL4742551	Binding affinity to CDK13 (unknown origin) by TR-FRET assay	B	C=CC(=O)N1CC=C(c2ccc([C@H](C)C(=O)Nc3cc(C4CC4)[nH]n3)cc2)CC1		CHEMBL4777358	=	IC50	nM	5.0	CHEMBL1795192	Homo sapiens	IC50	uM	0.005
	22945142	CHEMBL4742551	Binding affinity to CDK13 (unknown origin) by TR-FRET assay	B	C=CC(=O)N1CC=C(c2ccc(C(C(=O)Nc3cc(C4CC4)[nH]n3)C(C)C)cc2)CC1		CHEMBL4799698	=	IC50	nM	101.0	CHEMBL1795192	Homo sapiens	IC50	uM	0.10099999999999999
	22945143	CHEMBL4742551	Binding affinity to CDK13 (unknown origin) by TR-FRET assay	B	C=CC(=O)N1CC=C(c2ccc(C(C)C(=O)Nc3cc(C4CC4)[nH]n3)cn2)CC1		CHEMBL4778361	=	IC50	nM	3.0	CHEMBL1795192	Homo sapiens	IC50	uM	0.003
	22945144	CHEMBL4742551	Binding affinity to CDK13 (unknown origin) by TR-FRET assay	B	C=CC(=O)N1CC=C(c2ccc(C(C)C(=O)Nc3cc(C4CC4)[nH]n3)cn2)CC1		CHEMBL4778361	=	IC50	nM	77.0	CHEMBL1795192	Homo sapiens	IC50	uM	0.077
	22945145	CHEMBL4742551	Binding affinity to CDK13 (unknown origin) by TR-FRET assay	B	C=CC(=O)N1CC=C(c2ccc(C(C)C(=O)Nc3cc(C4CC4)[nH]n3)cn2)CC1		CHEMBL4778361	=	IC50	nM	6.0	CHEMBL1795192	Homo sapiens	IC50	uM	0.006
	22945146	CHEMBL4742551	Binding affinity to CDK13 (unknown origin) by TR-FRET assay	B	C=CC(=O)N1CC=C(c2ccc(C(C(=O)Nc3cc(C4CC4)[nH]n3)C(C)C)cn2)CC1		CHEMBL4790458	=	IC50	nM	398.0	CHEMBL1795192	Homo sapiens	IC50	uM	0.39799999999999996
	22945147	CHEMBL4742551	Binding affinity to CDK13 (unknown origin) by TR-FRET assay	B	C=CC(=O)NC1CC=C(c2ccc(C(C)C(=O)Nc3cc(C4CC4)[nH]n3)cc2)CC1		CHEMBL4800324	=	IC50	nM	19.0	CHEMBL1795192	Homo sapiens	IC50	uM	0.019
	22945148	CHEMBL4742551	Binding affinity to CDK13 (unknown origin) by TR-FRET assay	B	C=CC(=O)N1CCC=C(c2ccc(C(C)C(=O)Nc3cc(C4CC4)[nH]n3)cc2)CC1		CHEMBL4779633	=	IC50	nM	21.0	CHEMBL1795192	Homo sapiens	IC50	uM	0.021
	22945149	CHEMBL4742551	Binding affinity to CDK13 (unknown origin) by TR-FRET assay	B	C=CC(=O)NC1CCC(c2ccc(C(C)C(=O)Nc3cc(C4CC4)n[nH]3)cc2)CC1		CHEMBL4779066	=	IC50	nM	18.0	CHEMBL1795192	Homo sapiens	IC50	uM	0.018000000000000002
	22945150	CHEMBL4742551	Binding affinity to CDK13 (unknown origin) by TR-FRET assay	B	C=CC(=O)NC1CCC(c2ccc(C(C)C(=O)Nc3cc(C4CC4)n[nH]3)cc2)CC1		CHEMBL4779066	=	IC50	nM	45.0	CHEMBL1795192	Homo sapiens	IC50	uM	0.045
	22945151	CHEMBL4742551	Binding affinity to CDK13 (unknown origin) by TR-FRET assay	B	C=CC(=O)N1CCC(c2ccc([C@H](C)C(=O)Nc3cc(C4CC4)[nH]n3)cc2)CC1		CHEMBL4800122	=	IC50	nM	7.0	CHEMBL1795192	Homo sapiens	IC50	uM	0.006999999999999999
	22945152	CHEMBL4742551	Binding affinity to CDK13 (unknown origin) by TR-FRET assay	B	C=CC(=O)N1CCC(c2ccc(C(C)C(=O)Nc3cc(C4CC4)[nH]n3)cn2)CC1		CHEMBL4790705	=	IC50	nM	28.0	CHEMBL1795192	Homo sapiens	IC50	uM	0.027999999999999997
	22945153	CHEMBL4742551	Binding affinity to CDK13 (unknown origin) by TR-FRET assay	B	CCN(CC)C/C=C/C(=O)N1CC=C(c2ccc([C@H](C)C(=O)Nc3cc(C4CC4)[nH]n3)cc2)CC1		CHEMBL4785443	=	IC50	nM	72.0	CHEMBL1795192	Homo sapiens	IC50	uM	0.07200000000000001
	22945154	CHEMBL4742551	Binding affinity to CDK13 (unknown origin) by TR-FRET assay	B	C[C@H](C(=O)Nc1cc(C2CC2)[nH]n1)c1ccc(C2=CCN(C(=O)/C=C/CN(C)C)CC2)cc1		CHEMBL4787409	=	IC50	nM	18.8	CHEMBL1795192	Homo sapiens	IC50	uM	0.0188
	22945155	CHEMBL4742551	Binding affinity to CDK13 (unknown origin) by TR-FRET assay	B	C[C@H](C(=O)Nc1cc(C2CC2)[nH]n1)c1ccc(C2=CCN(C(=O)/C=C/CN3CCOCC3)CC2)cc1		CHEMBL4788085	=	IC50	nM	35.0	CHEMBL1795192	Homo sapiens	IC50	uM	0.035
	22945156	CHEMBL4742551	Binding affinity to CDK13 (unknown origin) by TR-FRET assay	B	C=CC(=O)N1CCN(c2ccc([C@H](C)C(=O)Nc3cc(C4CC4)[nH]n3)cc2)CC1		CHEMBL4781668	=	IC50	nM	81.0	CHEMBL1795192	Homo sapiens	IC50	uM	0.081
	22945157	CHEMBL4742551	Binding affinity to CDK13 (unknown origin) by TR-FRET assay	B	C=CC(=O)N1CCN(c2ccc([C@H](C)C(=O)Nc3cc(C4CC4)[nH]n3)cc2)CC1		CHEMBL4781668	=	IC50	nM	11.7	CHEMBL1795192	Homo sapiens	IC50	uM	0.0117
	22945158	CHEMBL4742551	Binding affinity to CDK13 (unknown origin) by TR-FRET assay	B	C=CC(=O)N1CCN(c2ccc([C@H](C)C(=O)Nc3cc(C4CC4)[nH]n3)cc2)CC1		CHEMBL4781668	=	IC50	nM	5810.0	CHEMBL1795192	Homo sapiens	IC50	uM	5.81
	22945159	CHEMBL4742551	Binding affinity to CDK13 (unknown origin) by TR-FRET assay	B	C=CC(=O)N1CCN(c2ccc(C(C)C(=O)Nc3cc(C4CC4)[nH]n3)cn2)CC1		CHEMBL4781396	=	IC50	nM	94.0	CHEMBL1795192	Homo sapiens	IC50	uM	0.094
	22945160	CHEMBL4742551	Binding affinity to CDK13 (unknown origin) by TR-FRET assay	B	C=CC(=O)NC1CCN(c2ccc(C(C)C(=O)Nc3cc(C4CC4)[nH]n3)cc2)CC1		CHEMBL4786663	=	IC50	nM	73.0	CHEMBL1795192	Homo sapiens	IC50	uM	0.073
	22945161	CHEMBL4742551	Binding affinity to CDK13 (unknown origin) by TR-FRET assay	B	C=CC(=O)N1CCC=C(c2ccc([C@H](C)C(=O)Nc3cc(C4CC4)[nH]n3)cc2)C1		CHEMBL4788447	=	IC50	nM	4.3	CHEMBL1795192	Homo sapiens	IC50	uM	0.0043
	22945162	CHEMBL4742551	Binding affinity to CDK13 (unknown origin) by TR-FRET assay	B	C=CC(=O)N1CCC=C(c2ccc(C(C)C(=O)Nc3cc(C4CC4)[nH]n3)cn2)C1		CHEMBL4781207	=	IC50	nM	6.0	CHEMBL1795192	Homo sapiens	IC50	uM	0.006
	22945163	CHEMBL4742551	Binding affinity to CDK13 (unknown origin) by TR-FRET assay	B	C=CC(=O)N1CCC=C(c2ccc(C(C)C(=O)Nc3cc(C4CC4)[nH]n3)cn2)C1		CHEMBL4781207	=	IC50	nM	153.0	CHEMBL1795192	Homo sapiens	IC50	uM	0.153
	22945164	CHEMBL4742551	Binding affinity to CDK13 (unknown origin) by TR-FRET assay	B	C=CC(=O)N1CCC=C(c2ccc(C(C)C(=O)Nc3cc(C4CC4)[nH]n3)cn2)C1		CHEMBL4781207	=	IC50	nM	3.0	CHEMBL1795192	Homo sapiens	IC50	uM	0.003
	22945165	CHEMBL4742551	Binding affinity to CDK13 (unknown origin) by TR-FRET assay	B	C=CC(=O)N1CC=C(c2ccc(C(C)C(=O)Nc3cc(C4CC4)[nH]n3)cn2)C1		CHEMBL4778676	=	IC50	nM	100.0	CHEMBL1795192	Homo sapiens	IC50	uM	0.1
	22945166	CHEMBL4742551	Binding affinity to CDK13 (unknown origin) by TR-FRET assay	B	C=CC(=O)N1CCC=C(c2ccc(C(CC)C(=O)Nc3cc(C4CC4)[nH]n3)cn2)C1		CHEMBL4778572	=	IC50	nM	93.0	CHEMBL1795192	Homo sapiens	IC50	uM	0.09300000000000001
	22945167	CHEMBL4742551	Binding affinity to CDK13 (unknown origin) by TR-FRET assay	B	C=CC(=O)N1CCC=C(c2ccc(C(C(=O)Nc3cc(C4CC4)[nH]n3)C(C)C)cc2)C1		CHEMBL4792842	=	IC50	nM	279.0	CHEMBL1795192	Homo sapiens	IC50	uM	0.27899999999999997
	22945168	CHEMBL4742551	Binding affinity to CDK13 (unknown origin) by TR-FRET assay	B	C=CC(=O)N1CCCC(c2ccc(C(C)C(=O)Nc3cc(C4CC4)[nH]n3)cn2)C1		CHEMBL4780788	=	IC50	nM	29.0	CHEMBL1795192	Homo sapiens	IC50	uM	0.028999999999999998
	22945169	CHEMBL4742551	Binding affinity to CDK13 (unknown origin) by TR-FRET assay	B	C=CC(=O)N1CCC=C(c2ccc(C(C)C(=O)Nc3cc(C4CC4)[nH]n3)cc2F)C1		CHEMBL4783704	=	IC50	nM	87.0	CHEMBL1795192	Homo sapiens	IC50	uM	0.087
	22945170	CHEMBL4742551	Binding affinity to CDK13 (unknown origin) by TR-FRET assay	B	C=CC(=O)N1CCC=C(c2ccc(C(C(=O)Nc3cc(C4CC4)[nH]n3)C(C)C)cn2)C1		CHEMBL4793480	=	IC50	nM	54.0	CHEMBL1795192	Homo sapiens	IC50	uM	0.054000000000000006
	22945171	CHEMBL4742551	Binding affinity to CDK13 (unknown origin) by TR-FRET assay	B	C=CC(=O)N1CC=C(c2ccc(C(C)C(=O)Nc3cc(C4CC4)[nH]n3)cc2F)CC1		CHEMBL4792293	=	IC50	nM	5.8	CHEMBL1795192	Homo sapiens	IC50	uM	0.0058
	22945172	CHEMBL4742551	Binding affinity to CDK13 (unknown origin) by TR-FRET assay	B	C=CC(=O)N1CC=C(c2ccc(C(C)C(=O)Nc3cc(C4CC4)[nH]n3)cc2F)CC1		CHEMBL4792293	=	IC50	nM	260.0	CHEMBL1795192	Homo sapiens	IC50	uM	0.26
	22945173	CHEMBL4742551	Binding affinity to CDK13 (unknown origin) by TR-FRET assay	B	C=CC(=O)N1CC=C(c2ccc(C(C)C(=O)Nc3cc(C4CC4)[nH]n3)cn2)C1		CHEMBL4778676	=	IC50	nM	6.9	CHEMBL1795192	Homo sapiens	IC50	uM	0.0069
	22945174	CHEMBL4742551	Binding affinity to CDK13 (unknown origin) by TR-FRET assay	B	C=CC(=O)N1CC=C(c2ccc(C(C)C(=O)Nc3cc(C4CC4)[nH]n3)cn2)C1		CHEMBL4778676	=	IC50	nM	6.0	CHEMBL1795192	Homo sapiens	IC50	uM	0.006
	22945175	CHEMBL4742551	Binding affinity to CDK13 (unknown origin) by TR-FRET assay	B	C=CC(=O)N1CCC(c2ccc(C(C)C(=O)Nc3cc(C4CC4)[nH]n3)cn2)C1		CHEMBL4776295	=	IC50	nM	6.0	CHEMBL1795192	Homo sapiens	IC50	uM	0.006
	22945176	CHEMBL4742551	Binding affinity to CDK13 (unknown origin) by TR-FRET assay	B	C=CC(=O)N1CCC=C(c2ccc(CC(=O)Nc3cc(C4CC4)[nH]n3)cn2)C1		CHEMBL4791883	=	IC50	nM	4.0	CHEMBL1795192	Homo sapiens	IC50	uM	0.004
	22945177	CHEMBL4742551	Binding affinity to CDK13 (unknown origin) by TR-FRET assay	B	C#CC(=O)N1CC=C(c2ccc(C(C)C(=O)Nc3cc(C4CC4)[nH]n3)cn2)CC1		CHEMBL4784656	=	IC50	nM	7.0	CHEMBL1795192	Homo sapiens	IC50	uM	0.006999999999999999
	22945178	CHEMBL4742551	Binding affinity to CDK13 (unknown origin) by TR-FRET assay	B	CC#CC(=O)N1CC=C(c2ccc(C(C)C(=O)Nc3cc(C4CC4)[nH]n3)cn2)CC1		CHEMBL4782687	=	IC50	nM	25.0	CHEMBL1795192	Homo sapiens	IC50	uM	0.025
	22945179	CHEMBL4742551	Binding affinity to CDK13 (unknown origin) by TR-FRET assay	B	CC#CC(=O)N1CCC=C(c2ccc(C(C)C(=O)Nc3cc(C4CC4)[nH]n3)cn2)C1		CHEMBL4794718	=	IC50	nM	19.0	CHEMBL1795192	Homo sapiens	IC50	uM	0.019
	22945180	CHEMBL4742551	Binding affinity to CDK13 (unknown origin) by TR-FRET assay	B	C=CC(=O)N1CC=C(c2ccc(CC(=O)Nc3cc(C4CC4)[nH]n3)cn2)C1		CHEMBL4797074	=	IC50	nM	0.9	CHEMBL1795192	Homo sapiens	IC50	uM	0.0009
	22945181	CHEMBL4742551	Binding affinity to CDK13 (unknown origin) by TR-FRET assay	B	C/C=C/C(=O)N1CCC=C(c2ccc(CC(=O)Nc3cc(C4CC4)[nH]n3)cn2)C1		CHEMBL4784925	=	IC50	nM	3.0	CHEMBL1795192	Homo sapiens	IC50	uM	0.003
	22945182	CHEMBL4742551	Binding affinity to CDK13 (unknown origin) by TR-FRET assay	B	CC#CC(=O)N1CCC=C(c2ccc(CC(=O)Nc3cc(C4CC4)[nH]n3)cn2)C1		CHEMBL4786926	=	IC50	nM	5.0	CHEMBL1795192	Homo sapiens	IC50	uM	0.005
	22945183	CHEMBL4742551	Binding affinity to CDK13 (unknown origin) by TR-FRET assay	B	C=C(C)C(=O)N1CCC=C(c2ccc(CC(=O)Nc3cc(C4CC4)[nH]n3)cn2)C1		CHEMBL4799777	=	IC50	nM	10.0	CHEMBL1795192	Homo sapiens	IC50	uM	0.01
	22945184	CHEMBL4742551	Binding affinity to CDK13 (unknown origin) by TR-FRET assay	B	C#CC(=O)N1CCC=C(c2ccc(CC(=O)Nc3cc(C4CC4)[nH]n3)cn2)C1		CHEMBL4794547	=	IC50	nM	84.0	CHEMBL1795192	Homo sapiens	IC50	uM	0.084
	22945185	CHEMBL4742551	Binding affinity to CDK13 (unknown origin) by TR-FRET assay	B	C=CC(=O)N1CC=C(c2ccc(CC(=O)Nc3cc(C4CC4)[nH]n3)cn2)CC1		CHEMBL4791767	=	IC50	nM	19.0	CHEMBL1795192	Homo sapiens	IC50	uM	0.019
	22990708	CHEMBL4775148	Inhibition of CDK13 (unknown origin)	B	CN(C)C/C=C/C(=O)Nc1ccc(C(=O)Nc2cccc(Nc3ncc(Cl)c(-c4c[nH]c5ccccc45)n3)c2)cc1		CHEMBL3603847	=	IC50	nM	225.0	CHEMBL1795192	Homo sapiens	IC50	nM	225.0
	23122481	CHEMBL4804832	Inhibition of human CDC2L5 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	64.0	CHEMBL1795192	Homo sapiens	Activity	%	64.0
	23123176	CHEMBL4805420	Inhibition of human CDC2L5 assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	55.0	CHEMBL1795192	Homo sapiens	Activity	%	55.0
	23123713	CHEMBL4805957	Inhibition of DNA-tagged human CDC2L5 assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	100.0	CHEMBL1795192	Homo sapiens	Activity	%	100.0
	23124049	CHEMBL4806268	Binding affinity towards CDK13 (unknown origin) by Discover X assay	B	Cn1cc(-n2cnc3c(NCc4nc5c(F)c(F)ccc5[nH]4)nc(N4CCOCC4)nc32)cn1		CHEMBL4852083	=	Kd	nM	5.0	CHEMBL1795192	Homo sapiens	Kd	nM	5.0
	23124050	CHEMBL4806268	Binding affinity towards CDK13 (unknown origin) by Discover X assay	B	Cn1cc(-n2cnc3c(NCc4nc5cc(Cl)c(Cl)cc5[nH]4)nc(N4CCOCC4)nc32)cn1		CHEMBL4877117	=	Kd	nM	5.0	CHEMBL1795192	Homo sapiens	Kd	nM	5.0
	23124051	CHEMBL4806268	Binding affinity towards CDK13 (unknown origin) by Discover X assay	B	COc1cc2nc(CNc3nc(N4CCOCC4)nc4c3ncn4-c3cnn(C)c3)[nH]c2cc1Cl		CHEMBL4855324	=	Kd	nM	2.0	CHEMBL1795192	Homo sapiens	Kd	nM	2.0
	23124052	CHEMBL4806268	Binding affinity towards CDK13 (unknown origin) by Discover X assay	B	Cc1cc(-n2cnc3c(NCc4nc5c(F)c(F)ccc5[nH]4)nc(N4CCOCC4)nc32)no1		CHEMBL4847754	=	Kd	nM	4.0	CHEMBL1795192	Homo sapiens	Kd	nM	4.0
	23124053	CHEMBL4806268	Binding affinity towards CDK13 (unknown origin) by Discover X assay	B	Fc1ccc2[nH]c(CNc3nc(N4CCOCC4)nc4c3ncn4-c3cscn3)nc2c1F		CHEMBL4868958	=	Kd	nM	6.0	CHEMBL1795192	Homo sapiens	Kd	nM	6.0
	23124054	CHEMBL4806268	Binding affinity towards CDK13 (unknown origin) by Discover X assay	B	FC(F)n1cc(-n2cnc3c(NCc4nc5cc(Cl)c(Cl)cc5[nH]4)nc(N4CCOCC4)nc32)cn1		CHEMBL4867928	=	Kd	nM	9.0	CHEMBL1795192	Homo sapiens	Kd	nM	9.0
	23124187	CHEMBL4806297	Inhibition of CDK13 (unknown origin) at 10 uM relative to control	B	Cn1cc(-n2cnc3c(NCc4nc5c(F)c(F)ccc5[nH]4)nc(N4CCOCC4)nc32)cn1		CHEMBL4852083	=	Inhibition	%	100.0	CHEMBL1795192	Homo sapiens	INH	%	100.0
	23124188	CHEMBL4806297	Inhibition of CDK13 (unknown origin) at 10 uM relative to control	B	COc1cc2nc(CNc3nc(N4CCOCC4)nc4c3ncn4-c3cnn(C)c3)[nH]c2cc1Cl		CHEMBL4855324	=	Inhibition	%	12.0	CHEMBL1795192	Homo sapiens	INH	%	12.0
	23124189	CHEMBL4806297	Inhibition of CDK13 (unknown origin) at 10 uM relative to control	B	Fc1cccc(-n2cnc3c(NCc4nc5c(F)c(F)ccc5[nH]4)nc(N4CCOCC4)nc32)c1		CHEMBL4211454	=	Inhibition	%	100.0	CHEMBL1795192	Homo sapiens	INH	%	100.0
	23124190	CHEMBL4806297	Inhibition of CDK13 (unknown origin) at 10 uM relative to control	B	Cc1cc(-n2cnc3c(NCc4nc5c(F)c(F)ccc5[nH]4)nc(N4CCOCC4)nc32)no1		CHEMBL4847754	=	Inhibition	%	100.0	CHEMBL1795192	Homo sapiens	INH	%	100.0
	23124193	CHEMBL4806300	Inhibition of CDK13 (unknown origin)	B	Cn1cc(-n2cnc3c(NCc4nc5c(F)c(F)ccc5[nH]4)nc(N4CCOCC4)nc32)cn1		CHEMBL4852083	=	IC50	nM	5.0	CHEMBL1795192	Homo sapiens	IC50	nM	5.0
	23124194	CHEMBL4806300	Inhibition of CDK13 (unknown origin)	B	Fc1cccc(-n2cnc3c(NCc4nc5c(F)c(F)ccc5[nH]4)nc(N4CCOCC4)nc32)c1		CHEMBL4211454	=	IC50	nM	10.0	CHEMBL1795192	Homo sapiens	IC50	nM	10.0
	23124195	CHEMBL4806300	Inhibition of CDK13 (unknown origin)	B	Cc1cc(-n2cnc3c(NCc4nc5c(F)c(F)ccc5[nH]4)nc(N4CCOCC4)nc32)no1		CHEMBL4847754	=	IC50	nM	4.0	CHEMBL1795192	Homo sapiens	IC50	nM	4.0
	23124196	CHEMBL4806300	Inhibition of CDK13 (unknown origin)	B	Cn1cc(-n2cnc3c(NCc4nc5cc(Cl)c(Cl)cc5[nH]4)nc(N4CCOCC4)nc32)cn1		CHEMBL4877117	=	IC50	nM	5.0	CHEMBL1795192	Homo sapiens	IC50	nM	5.0
	23124442	CHEMBL4806437	Inhibition of human CDC2L5 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	71.0	CHEMBL1795192	Homo sapiens	Activity	%	71.0
	23124443	CHEMBL4806437	Inhibition of human CDC2L5 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	80.0	CHEMBL1795192	Homo sapiens	Activity	%	80.0
	23234029	CHEMBL4827608	Inhibition of wild-type human partial length CDC2L5 (H675 to S1054 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	O=C(O)c1ccc(-c2ccnc3[nH]c(-c4ccccc4)nc23)cc1C1CCCC1		CHEMBL4870467	<	Activity	%	10.0	CHEMBL1795192	Homo sapiens	Activity	%	10.0
Not Active	23317316	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	95.0	CHEMBL1795192	Homo sapiens	% Control	%	95.0
Not Active	23317784	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	100.0	CHEMBL1795192	Homo sapiens	% Control	%	100.0
Not Active	23318455	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	67.0	CHEMBL1795192	Homo sapiens	% Control	%	67.0
Not Active	23318934	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	87.0	CHEMBL1795192	Homo sapiens	% Control	%	87.0
Not Active	23319573	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	52.5	CHEMBL1795192	Homo sapiens	% Control	%	52.5
Not Active	23320046	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	100.0	CHEMBL1795192	Homo sapiens	% Control	%	100.0
Not Active	23320724	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	100.0	CHEMBL1795192	Homo sapiens	% Control	%	100.0
Not Active	23321192	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	85.0	CHEMBL1795192	Homo sapiens	% Control	%	85.0
Slightly Active	23321822	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	45.0	CHEMBL1795192	Homo sapiens	% Control	%	45.0
Not Active	23322290	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	81.0	CHEMBL1795192	Homo sapiens	% Control	%	81.0
Not Active	23322979	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	98.0	CHEMBL1795192	Homo sapiens	% Control	%	98.0
Not Active	23323447	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	100.0	CHEMBL1795192	Homo sapiens	% Control	%	100.0
Not Active	23324301	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	86.6	CHEMBL1795192	Homo sapiens	% Control	%	86.6
Not Active	23324936	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	93.0	CHEMBL1795192	Homo sapiens	% Control	%	93.0
Not Active	23325404	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	92.0	CHEMBL1795192	Homo sapiens	% Control	%	92.0
Not Active	23326051	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	92.0	CHEMBL1795192	Homo sapiens	% Control	%	92.0
Not Active	23326519	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	100.0	CHEMBL1795192	Homo sapiens	% Control	%	100.0
Not Active	23327219	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	88.0	CHEMBL1795192	Homo sapiens	% Control	%	88.0
Not Active	23327687	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	89.0	CHEMBL1795192	Homo sapiens	% Control	%	89.0
Not Active	23328274	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	87.0	CHEMBL1795192	Homo sapiens	% Control	%	87.0
Not Active	23328742	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	100.0	CHEMBL1795192	Homo sapiens	% Control	%	100.0
Not Active	23329688	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	62.0	CHEMBL1795192	Homo sapiens	% Control	%	62.0
Not Active	23330156	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	88.0	CHEMBL1795192	Homo sapiens	% Control	%	88.0
Not Active	23330912	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	100.0	CHEMBL1795192	Homo sapiens	% Control	%	100.0
Not Active	23331380	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	96.0	CHEMBL1795192	Homo sapiens	% Control	%	96.0
Not Active	23331967	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	59.0	CHEMBL1795192	Homo sapiens	% Control	%	59.0
Not Active	23332435	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	64.2	CHEMBL1795192	Homo sapiens	% Control	%	64.2
Not Active	23333151	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	100.0	CHEMBL1795192	Homo sapiens	% Control	%	100.0
Not Active	23333790	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	89.0	CHEMBL1795192	Homo sapiens	% Control	%	89.0
Not Active	23334258	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	93.0	CHEMBL1795192	Homo sapiens	% Control	%	93.0
Not Active	23335237	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	73.0	CHEMBL1795192	Homo sapiens	% Control	%	73.0
Not Active	23335705	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	77.0	CHEMBL1795192	Homo sapiens	% Control	%	77.0
Not Active	23336332	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	85.0	CHEMBL1795192	Homo sapiens	% Control	%	85.0
Not Active	23336800	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	82.0	CHEMBL1795192	Homo sapiens	% Control	%	82.0
Not Active	23337881	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	83.0	CHEMBL1795192	Homo sapiens	% Control	%	83.0
Not Active	23338349	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	91.0	CHEMBL1795192	Homo sapiens	% Control	%	91.0
Not Active	23338961	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	100.0	CHEMBL1795192	Homo sapiens	% Control	%	100.0
Not Active	23339429	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	91.0	CHEMBL1795192	Homo sapiens	% Control	%	91.0
Not Active	23340066	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	100.0	CHEMBL1795192	Homo sapiens	% Control	%	100.0
Not Active	23340534	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	100.0	CHEMBL1795192	Homo sapiens	% Control	%	100.0
Not Active	23341191	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	100.0	CHEMBL1795192	Homo sapiens	% Control	%	100.0
Not Active	23341659	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	100.0	CHEMBL1795192	Homo sapiens	% Control	%	100.0
Not Active	23342275	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	100.0	CHEMBL1795192	Homo sapiens	% Control	%	100.0
Not Active	23342743	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	100.0	CHEMBL1795192	Homo sapiens	% Control	%	100.0
Not Active	23343373	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	83.0	CHEMBL1795192	Homo sapiens	% Control	%	83.0
Not Active	23343841	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	72.0	CHEMBL1795192	Homo sapiens	% Control	%	72.0
Not Active	23344479	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	92.0	CHEMBL1795192	Homo sapiens	% Control	%	92.0
Not Active	23345052	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	77.0	CHEMBL1795192	Homo sapiens	% Control	%	77.0
Not Active	23345520	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	90.0	CHEMBL1795192	Homo sapiens	% Control	%	90.0
Not Active	23346097	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	89.5	CHEMBL1795192	Homo sapiens	% Control	%	89.5
Slightly Active	23346566	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	45.7	CHEMBL1795192	Homo sapiens	% Control	%	45.7
Slightly Active	23347176	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	45.7	CHEMBL1795192	Homo sapiens	% Control	%	45.7
Not Active	23347657	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	79.0	CHEMBL1795192	Homo sapiens	% Control	%	79.0
Not Active	23348236	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL1795192	Homo sapiens	% Control	%	100.0
Not Active	23348704	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	96.0	CHEMBL1795192	Homo sapiens	% Control	%	96.0
Not Active	23349291	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	92.0	CHEMBL1795192	Homo sapiens	% Control	%	92.0
Not Active	23349909	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	99.0	CHEMBL1795192	Homo sapiens	% Control	%	99.0
Not Active	23350377	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	100.0	CHEMBL1795192	Homo sapiens	% Control	%	100.0
Not Active	23350982	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	95.0	CHEMBL1795192	Homo sapiens	% Control	%	95.0
Not Active	23351450	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	86.0	CHEMBL1795192	Homo sapiens	% Control	%	86.0
Not Active	23352474	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	84.0	CHEMBL1795192	Homo sapiens	% Control	%	84.0
Not Active	23352942	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	86.0	CHEMBL1795192	Homo sapiens	% Control	%	86.0
Not Active	23353824	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL1795192	Homo sapiens	% Control	%	100.0
Not Active	23354292	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL1795192	Homo sapiens	% Control	%	100.0
Not Active	23355024	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	100.0	CHEMBL1795192	Homo sapiens	% Control	%	100.0
Not Active	23355492	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	100.0	CHEMBL1795192	Homo sapiens	% Control	%	100.0
Not Active	23356128	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	96.0	CHEMBL1795192	Homo sapiens	% Control	%	96.0
Not Active	23356596	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	100.0	CHEMBL1795192	Homo sapiens	% Control	%	100.0
Not Active	23357205	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	98.0	CHEMBL1795192	Homo sapiens	% Control	%	98.0
Not Active	23357852	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	100.0	CHEMBL1795192	Homo sapiens	% Control	%	100.0
Not Active	23358320	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	98.0	CHEMBL1795192	Homo sapiens	% Control	%	98.0
Not Active	23358906	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	67.6	CHEMBL1795192	Homo sapiens	% Control	%	67.6
Not Active	23359504	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	100.0	CHEMBL1795192	Homo sapiens	% Control	%	100.0
Not Active	23359972	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	100.0	CHEMBL1795192	Homo sapiens	% Control	%	100.0
Not Active	23360557	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	79.0	CHEMBL1795192	Homo sapiens	% Control	%	79.0
Not Active	23361025	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	100.0	CHEMBL1795192	Homo sapiens	% Control	%	100.0
Not Active	23361598	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	90.0	CHEMBL1795192	Homo sapiens	% Control	%	90.0
Not Active	23362134	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	100.0	CHEMBL1795192	Homo sapiens	% Control	%	100.0
Not Active	23362602	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	100.0	CHEMBL1795192	Homo sapiens	% Control	%	100.0
Not Active	23364244	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	100.0	CHEMBL1795192	Homo sapiens	% Control	%	100.0
Not Active	23364712	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	63.0	CHEMBL1795192	Homo sapiens	% Control	%	63.0
Not Active	23365451	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	100.0	CHEMBL1795192	Homo sapiens	% Control	%	100.0
Not Active	23365994	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	100.0	CHEMBL1795192	Homo sapiens	% Control	%	100.0
Not Active	23366584	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	79.0	CHEMBL1795192	Homo sapiens	% Control	%	79.0
Not Active	23367052	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	100.0	CHEMBL1795192	Homo sapiens	% Control	%	100.0
Not Active	23367930	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	100.0	CHEMBL1795192	Homo sapiens	% Control	%	100.0
Not Active	23368398	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	100.0	CHEMBL1795192	Homo sapiens	% Control	%	100.0
Not Active	23368997	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	100.0	CHEMBL1795192	Homo sapiens	% Control	%	100.0
Not Active	23369465	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	84.0	CHEMBL1795192	Homo sapiens	% Control	%	84.0
Not Active	23370433	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	100.0	CHEMBL1795192	Homo sapiens	% Control	%	100.0
Not Active	23370901	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	87.0	CHEMBL1795192	Homo sapiens	% Control	%	87.0
Not Active	23371710	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	61.0	CHEMBL1795192	Homo sapiens	% Control	%	61.0
Not Active	23372178	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	100.0	CHEMBL1795192	Homo sapiens	% Control	%	100.0
	23372683	CHEMBL4884648	CHED(CD13PHS1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4088216		IC50	nM	1000.0	CHEMBL1795192	Homo sapiens	pIC50		6.0
	23373092	CHEMBL4884939	CHED(CD13PHS1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21		CHEMBL4549667		IC50	nM	1000.0	CHEMBL1795192	Homo sapiens	pIC50		6.0
	23373453	CHEMBL4885230	CHED(CD13PHS1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL1795192	Homo sapiens	pIC50		6.0
Not Active	23375605	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	100.0	CHEMBL1795192	Homo sapiens	% Control	%	100.0
Not Active	23376073	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	100.0	CHEMBL1795192	Homo sapiens	% Control	%	100.0
Not Active	23376651	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	75.0	CHEMBL1795192	Homo sapiens	% Control	%	75.0
Not Active	23377120	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	90.0	CHEMBL1795192	Homo sapiens	% Control	%	90.0
Not Active	23377978	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	96.0	CHEMBL1795192	Homo sapiens	% Control	%	96.0
Not Active	23378446	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	92.0	CHEMBL1795192	Homo sapiens	% Control	%	92.0
Not Active	23379613	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	98.0	CHEMBL1795192	Homo sapiens	% Control	%	98.0
Not Active	23380081	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	100.0	CHEMBL1795192	Homo sapiens	% Control	%	100.0
Not Active	23380775	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	100.0	CHEMBL1795192	Homo sapiens	% Control	%	100.0
Not Active	23381423	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	100.0	CHEMBL1795192	Homo sapiens	% Control	%	100.0
Not Active	23381891	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	100.0	CHEMBL1795192	Homo sapiens	% Control	%	100.0
Not Active	23382515	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	94.0	CHEMBL1795192	Homo sapiens	% Control	%	94.0
Not Active	23382983	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	82.0	CHEMBL1795192	Homo sapiens	% Control	%	82.0
Not Active	23384898	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	100.0	CHEMBL1795192	Homo sapiens	% Control	%	100.0
Not Active	23385365	CHEMBL4879622	KinomeScan assay: inhibition of CDC2L5	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	100.0	CHEMBL1795192	Homo sapiens	% Control	%	100.0
